ArticleOPEN ACCESS

Immune checkpoint inhibitor-related cutaneous adverse events

Asia-Pacific Journal of Clinical Oncology
DOI: 10.1111/ajco.13364
10Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cutaneous toxicities are the most prevalent immune-related adverse events. Various reactions have been reported. In this review, we summarized the clinicopathologic manifestations, treatment strategies, relevance to tumor outcomes, and rechallenge considerations of cutaneous immune-related adverse events.

Author supplied keywords

Cite

CITATION STYLE

APA

He, C., & Qu, T. (2020, October 1). Immune checkpoint inhibitor-related cutaneous adverse events. Asia-Pacific Journal of Clinical Oncology. Blackwell Publishing Ltd. https://doi.org/10.1111/ajco.13364

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free